Stanrose Mafatlal Investments & Finance Intrinsic Value
Stanrose Mafatlal Investments & Finance intrinsic value. Stanrose Mafatlal Investments & Finance (STANROS) median intrinsic value is ₹60.00 from 3 valuation models (range ₹20–₹68), vs current price ₹67.56 — -11.2% downside (Trading Above Median Value), margin of safety -12.6%. For current market price and key ratios, visit Stanrose Mafatlal Investments share price screener.
STANROS Valuation Methods Summary — DCF, Graham Number & P/E
Stanrose Mafatlal Investments & Finance intrinsic value across 3 models vs current price ₹67.56 — upside/downside and value range per method. Read STANROS dividend history for the complete payout history and dividend yield track record.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹60.00 | ₹54.00 - ₹66.00 | -11.2% | Book Value/Share: ₹75.00, P/B: 0.8x |
| Revenue Multiple Method | revenue | ₹20.27 | ₹18.24 - ₹22.30 | -70.0% | Revenue/Share: ₹20.00, P/S: 1.0x |
| Simple DCF (5Y) | dcf | ₹67.92 | ₹54.34 - ₹81.50 | +0.5% | CF Growth: 15.0%, Discount: 15% |
STANROS Intrinsic Value vs Market Price — All Valuation Models
Stanrose Mafatlal Investments & Finance fair value range ₹20–₹68 vs current market price ₹67.56 across 3 valuation models. Compare with STANROS fair value to assess whether the stock is under or overvalued.
STANROS Intrinsic Value Analysis — Undervalued or Overvalued?
Stanrose Mafatlal Investments & Finance median intrinsic value ₹60.00, current price ₹67.56 — Trading Above Median Value by 11.2%, margin of safety -12.6%.
What is the intrinsic value of STANROS?
Based on our comprehensive analysis using 3 different valuation methods, the estimated intrinsic value of Stanrose Mafatlal Investments & Finance (STANROS) is ₹60.00 (median value). With the current market price of ₹67.56, this represents a -11.2% variance from our estimated fair value.
The valuation range spans from ₹20.27 to ₹67.92, indicating ₹20.27 - ₹67.92.
Is STANROS undervalued or overvalued?
Based on our multi-method analysis, Stanrose Mafatlal Investments & Finance (STANROS) appears to be trading above median value by approximately 11.2%.
STANROS Financial Health — Key Ratios vs Industry Benchmarks
Stanrose Mafatlal Investments & Finance financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 3.00 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | -13.3% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | -41.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.24x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
STANROS Cash Flow Quality — Operating & Free Cash Flow
Stanrose Mafatlal Investments & Finance operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹2 Cr | ₹2 Cr | Positive Free Cash Flow | 8/10 |
| March 2025 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹-1 Cr | ₹-1 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹1 Cr | ₹1 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹1 Cr | ₹1 Cr | Positive Free Cash Flow | 8/10 |